ach year, millions of children receive surgical operation with general anesthesia (1) . Accumulative evidence has suggested that children exposed to anesthesia, especially with multiple exposures, less than 4 year old, have an increased risk for the long-term diminution of language abilities and cognition (2) (3) (4) . Sevoflurane is one of the most commonly used anesthetics for children due to its sweet-smelling, nonflammable, fast acting, and short recovery time. Although recent studies have shown that sevoflurane can induce neuroapoptosis in developing brain and subsequently cause long-lasting learning and memory deficits later in life (5, 6 ), the precise mechanisms underlying the neurotoxicity of general anesthesia remain largely to be determined.
Epigenetic mechanisms, including DNA methylation, posttranslational his- Original Article tone modification (acetylation, phosphorylation, and methylation, et al), and small noncoding RNAs, play important roles in human neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and postoperative cognitive dysfunction (7) (8) (9) (10) (11) . Methylated DNA induces gene silencing via recruiting methyl CpGbinding proteins. However, the histone modification can result in activation or repression of gene transcription. For example dimethylation lysine 9 of histone H3 (H3K9me2) is correlated with transcriptional silencing, whereas trimethylation lysine 9 of histone H3 (H3K4me3) is linked to active transcription (9) . Especially, histone lysine methylation plays a critical role in psychiatric disorders, including schizophrenia, depression, and posttraumatic stress disorder (12, 13) . G9a and G9a-like protein (GLP), a class of histone lysine methyltransferases, are primary enzymes for H3K9me2 (14) that suppress the expression of genes (15) . More importantly, G9a is also reported to be essential for neuronal function during brain development (16) .
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In the present study, we hypothesized that sevoflurane exposure at postnatal day (P5- 7) may enhance hippocampal G9a expression and then lead to the hippocampal caspase-3 activation and the increase of H3K9me2, which may induce cognitive impairment in adolescent rats ( Figure 1A ). So in this study, we aimed to explore the relationship between the G9a-mediated H3K9me2 and the sevoflurane-induced longterm neurobehavioral abnormities by the inhibition of G9a/GLP activity.
MATERIALS AND METHODS

Animals
The study protocol was approved by the Ethics Committee of Jinling Hospital, Nanjing University and the experiments were performed in accordance with the Guideline for the Care and Use of Laboratory Animals from the National Institutes of Health, USA. Male Sprague-Dawley rats aged from P5 to P55 days were used for sevoflurane anesthesia and subsequent analyses (Figure 1B) . The pups after birth were housed with the dam until weaning in the P21. All rats were housed in a standard condition under a 12:12 hour light/dark cycle with lights from 7:00 to 19:00, with the room temperature of 23 ± 1℃ , and free access to food and water.
We used three different sets of rats for the following experiments. The first set of rats (N=36) were used to study the neurotoxicity of sevoflurane (the 0, 4, 8 and 24 hours after the end of last anesthesia) and the suitable dose of Bix (Bix-01294, 2-(Hexahydro-4-methyl-1H-1, 4-diazepin-1-yl)-6, 7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine trihydrochloride) (Cayman, Ann Arbor, MI, USA) to improve the detrimental effect of sevoflurane exposure. The second set of rats (N=36) were used Figure A showed the proposed mechanism of action: sevoflurane exposure at P5-7 enhances hippocampal G9a expression and activity (→) leads to hippocampal caspase-3 activation and the increase of H3K9me2 (→) leads to cognitive impairment in adolescent rats. Inhibition of G9a/GLP activity by Bix (---) prevents sevoflurane-induced increase in H3K9me2 and rescues neuroapotosis (cleaved caspase-3) in neonatal hippocampus. Figure B showed to study the effect of Bix on the sevoflurane anesthesia at P8 and P35. The third set of rats (N= 32) were used for behavioral tests. The second and third sets of rats were equally randomized into one of the four groups: control + vehicle (Con + Veh) group, control + Bix (Con + Bix) group, sevoflurane + vehicle (Sev + Veh) group, or sevoflurane + Bix (Sev + Bix) group.
Sevoflurane Anesthesia and Drug Treatment
Anesthesia was induced with 6% sevoflurane by 100% of 2 L/minute O2 for 3 minutes and maintained with 3% sevoflurane by 100% of 2 L/minute O2 for 1 hour and 57 minutes in a thermostatic chamber daily for three successive days from P5 to P7. Previously, we have shown that this anesthesia protocol could cause the neurobehavioral abnormalities without respiratory depression (6) . The rats breathed spontaneously, and concentrations of anesthetic and oxygen were measured continuously using a calibrated Datex side stream analyser that sampled from the interior of the chamber. Temperature of the rats was maintained at 37±0.5℃ during anesthesia by heating lamps and heating pads. The pups returned to their mother cage after recovery from anesthesia. Accordingly, Bix was diluted with vehicle (normal saline) to final 0.2 mg/ml and subcutaneously injected with 0.25, 0.5, and 1 mg/kg 15 minutes before each sevoflurane exposure, respectively.
Behavioral Tests
All behavioral tests were conducted in a sound-isolated room with the instruments (Shanghai Softmaze Information Technology Co. Ltd., Shanghai, China). The rats used for behavioral tests were not analyzed in further biochemical experiments.
Open Field (OF) Test
At P35, the rat was placed into the OF apparatus (XR-XZ301, 100 cm × 100 cm × 40 cm black plastic box) for 10 minutes. The behaviors of each rat were traced by a camera for further analysis. At the end of each test, the surface of the arena was thoroughly cleaned with 75% alcohol to avoid the presence of olfactory cue.
Fear Conditioning (FC) Test
The FC test was performed by using the FC paradigm (XR-XC404, 30 cm × 30 cm × 45 cm soundproof chamber) at P39-41. The FC test was a simple and sensitive test of hippocampus-dependent and hippocampus-independent memory function. During the training, the rat was allowed to explore the training chamber for 180 seconds. Within the last 30 seconds, the rat was subjected to a tone (30 seconds, 70 dB, 3000 HZ) with a terminating 2 seconds electrical footshock (0.5 mA), followed by an additional 30 seconds without any stimulation. The rat was placed in the training chamber for 5 minutes (context association testing, without tone or foot-shock) after 24 hours. Then, the cue conditioning test was conducted on the next day in a novel training chamber with a radically changed context. A 3 minutes exploration of the new context was followed by 3 minutes of tone presentation (70 dB, 3000 HZ, without footshock). Fear response was reflected by the time of freezing.
Morris Water Maze (MWM) Test
The MWM task was carried out at P49 -55. In the spatial discrimination trials, the rat was placed in a round tank (XR-XM101, diameter 120 cm, height 50 cm) filled with opaque water containing an escape platform (height 22 cm) submerged 2 cm below the surface of water. The platform remained in the same location relative to the four visual cues in the tank. The rat received four swims per day for six consecutive days using a 15 seconds interval on platform between swims. Every training session, the rat was placed carefully in the water next to the maze wall and allowed to swim until finding the platform or for 60 second (whichever came first).
The time taken to climb the platform (latency) was recorded. In the probe trials (on the seventh day), the rat was placed in the tank for 60 seconds during which the escape platform was removed from the tank, the time spent in swimming in the target quadrant and the swimming route were recorded. The water temperature was maintained at 22 ± 1℃ . After finished the per day swimming task, the rat was removed from the tank, dried with a clean towel, and placed in a holding box that is warmed with a temperature-controlled heating pad placed beneath it.
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Western Blot
The Western blot analysis was performed previously (17) . The rat was sacrificed by 2% sodium pentobarbital (70 mg/kg, intraperitoneal [i.p.]) at the indicated time points ( 0, 4, 8, and 24 hours [P8] after the end of last sevoflurane exposure and P35), and the hippocampus was dissected, frozen, and stored at -80℃ . On the day of analysis, the brain tissues were allowed to equilibrate to a temperature of 4℃ . Tissue protein was collected by using the protein extraction kit (Nanjing KeyGEN Biotech, Nanjing, China). The protein concentrations were determined using the QuantiPro BCA Assay kit (Nanjing Key-GEN Biotech, Nanjing, China). Protein extracts (70 μg protein/lane) were separated using polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene fluoride membranes with an electrophoretic transfer system. Membranes were blocked with 5% nonfatdried milk in tris-buffered saline tween (TBST) for 1 hour and then incubated with the primary antibodies: anti-rabbit cleaved caspase-3 (polyclonal, #9661, 1:1000, Cell Signaling Technology, Danvers, MA, USA), anti-rabbit-G9a (monoclonal, #3306, 1:1000, Cell Signaling Technology, Danvers, MA, USA), anti-rabbit H3K9me2 (monoclonal, #4658, 1:1000, Cell Signaling Technology, Danvers, MA, USA) and anti-rabbit β-actin (polyclonal, #YM3214, 1:3000, ImmunoWay, New Jersey, USA) overnight in a room at 4℃ . After thorough washing, membranes were incubated in 5% nonfat-dried milk in TBST with the secondary antibody (goat anti-rabbit, #AP132P, 1:5000, Millipore, Darmstadt, Germany) for 2 hours at room temperature. Enhanced chemiluminescent and the Image Quant Software (Syngene, Cambridge, United Kingdom) were used to visualize and quantitate the immunoreactivity, respectively.
Immunocytochemistry
The immunohistochemistry was performed as we described previously (6) . Briefly, the rats were anesthetize with 2% sodium pentobarbital (70 mg/kg, i.p.) at P8, and perfused with phosphate buffered saline (PBS), followed by freshly prepared 4% paraformaldehyde. Sections of paraffin-embedded tissue (4 μ m) were cut and mounted on Vectabond adhesive-coated slides 
Statistical Analysis
The statistical analyses were performed using the Prism software (GraphPad, San Diego, CA, USA). The data were presented as the mean ± standard error of the mean (SEM) and statistically analyzed by one-way analysis of variance (ANOVA) or two-way ANOVA with Bonferroni's post hoc test. Pearson's rank correlation coefficient method was used for correlation analysis. In all of the comparisons, P<0.05 was considered to indicate statistical significance.
RESULTS
The Effect of Repeated Sevoflurane Exposure on the Cleaved Caspase-3 and G9a Expressions in the Neonatal Hippocampus
Hippocampal cleaved caspase-3 was increased at 24 hours after the last sevoflurane exposure (P<0.01, Figure 2A) . Consistently, the results of immunohistochemistry showed significantly increased apoptotic cells in the hippocampus in the Sev + Veh group compared with the Con + Veh group (P<0.01, Figure 2B ). Hippocampal G9a expression including the 165 kDa G9a-L and 140 kDa G9a-S isoforms was also increased at 24 hours after the last sevoflurane exposure (P<0.01, Figure 2C 
Dose Response of Bix on the Cleaved Caspase-3 Expression after Repeated Sevoflurane Exposure in the Neonatal Hippocampus
Because the repeated sevoflurane exposure-induced neurotoxity was most obvious at 24 hours after the last sevoflurane exposure in our previous experiment, we chose this time point to study the effect of Bix treatment on neuroapoptosis. Our results indicated that Bix could dose-dependently inhibit sevoflurane-induced hippocampal caspase-3 activation (Figure 3) , and 1 mg/kg of Bix had the maximal effect. Thus, we chose the dose of 1 mg/kg in our subsequent experiments (P>0.05). Figure A showed the hippocampal level of cleaved caspase-3 at 0, 4, 8 and 24 hours after the last sevoflurane exposure. Figure B showed the hippocampal cleaved caspase-3 + cells 24 hours after the last sevoflurane exposure. Figure C showed the hippocampal G9a protein including the 165 kDa G9a-L and 140 kDa G9a-S isoforms levels at 0, 4, 8 and 24 hours after the last sevoflurane exposure. Figure D showed the hippocampal level of cleaved caspase-3 at 0, 4, 8 and 24 hours after the last sevoflurane exposure. Scale bars=500 μm. Each data point represent mean ± the SEM (N=3, *P<0.05 or **P<0.01 versus the Con + Veh group or the 0 hour after the last sevoflurane exposure).
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Bix Treatment Prevented Repeated Sevoflurane Exposure-Induced G9a and H3K9me2 Expressions in the Neonatal and Adolescent Hippocampus
Repeated sevoflurane exposure increased G9a expression in the hippocampus at P8 and P35, which was prevented by Bix treatment (P<0.01, Figure 5A and B). Two-way ANOVA with Bonferroni's post hoc demonstrated significant effects of sevoflurane (vs. Con) (P8, F1, 2= 92.778, P=0.011; P35, F1, 2= 180.233, P=0.006). A significant interaction between sevoflurane and Bix was observed for the hippocampal level of G9a at P8 and P35 (P8, F1, 2= 80.997, P=0.012; P35, F1, 2= 164.320, P=0.006).
Repeated sevoflurane exposure increased hippocampal H3K9me2 level at P8 and P35, whereas Bix only decrease hippocampal H3K9me2 level at P35 (P<0.05, Figure 5D ). However, the hippocampal H3K9me2 level in the Sev + Bix group was similar when compared with the Con + Veh group at P8 (P>0.05, Figure 5C ). Furthermore, two-way ANOVA for the hippocampal H3K9me2 level showed a significant interaction between sevoflurane and Bix (P8, F1, 2= 21.196, P=0.044; P35, F1, 2= 209.452, P=0.005). These results suggested that G9a mediated-increased H3K9me2 expression may be one mechanism responsible for repeated sevoflurane exposure-induced apoptosis in the hippocampus.
Bix Prevented Repeated Sevoflurane ExposureInduced Behavioral Abnormalities in Adolescent Rats
In the OF test, repeated sevoflurane exposure had no effect on the total distance compared with the Con + Veh group (P>0.05, Figure 6A) . Two-way ANOVA demonstrated no significant interaction between sevoflurane and Bix (F1, 7= 0.220, P=0.635). As shown in figure 6B and C, in the FC test, the freezing time to context was significantly decreased in the Sev + Veh group compared with the Con + Veh group (P<0.01), which was rescued by Bix treatment (P<0.01). Two-way ANOVA for the freezing time to context presented a significant effect of sevoflurane (vs. Con) (F1, 7= 16.139, P=0.005) and a significant interaction between sevoflurane and Bix (F1, 7= 6.640, P=0.037). There was no significant difference in the freezing time to tone among the groups (P>0.05) and no significant interaction between sevoflurane and Bix (F1, 7= 1.331, P=0.278). In the MWM training phase, there was no significantly difference in latency spent to find the underwater platform among the groups (P>0.05, Figure 6D ). In the testing phase, the time spent in the target quadrant of the Sev + Veh group was significantly increased than that in the Con + Veh group (P<0.01, Figure 6E) , which was reversed by Bix treatment (P<0.05, Figure 6E ). In addition, two-way ANOVA with Bonferroni's post hoc indicated a significant effect of sevoflurane (vs. Con) (F1, 7 
DISCUSSION
In the current study, we demonstrated that repeated sevoflurane exposure induced neurodegeneration and neurobehavioral abnormities in the developing brain, which was consistent with previous studies (18) (19) (20) . Furthermore, we found that sevoflurane-induced cognitive impairment was associated with G9a-mediated enhancement of H3K9me2. Notably, pharmacological inhibition of G9a activity with Bix prior to sevoflurane exposure could prevent the neuroapoptosis and cognitive impairment later in life ( Figure 1A) . Accumulating evidence has suggested that neonatal exposure to anesthesia drugs can cause widespread neuroapoptosis and long-term cognitive impairment later in life (5, 19 proposed that 3% sevoflurane exposure to neonatal rodents can cause long-term cognitive impairment, but in another study comparing isoflurane to sevoflurane exposure, neither isoflurane nor sevoflurane was found to be associated with the impaired cognitive impairment (19, 21) . These discrepancies might be attributed to the differences in methods of anesthetic exposure, animal species, anesthetic concentrations, anesthetic durations, and so on. Hippocampus is the primary region of the brain controlling the formation of memories and learned behaviors, which is discovered by the context associated FC test and the MWM test. In the present study, we found that sevoflurane-exposed rats had the decreased freezing time to context, but not the freezing time to tone in FC test. Furthermore, sevoflurane exposure induced significant spatial memory impairment as assessed in the MWM test. These results suggested that sevoflurane exposure impaired the hippocampus-dependent learning and memory in developing brain, which was supported by previous studies demonstrating that sevoflurane exposure influenced the hippocampus-dependent memory negatively (22) (23) (24) . However, the molecular mechanism is not fully understood. Epigenetic modification of genome is a major point of regulation governing many developmental processes. Early-life experience can shape the developing brain with long-term implication for brain functions and behaviors, which is closely related to epigenetic modification (10) . In eukaryotic nuclei, DNA with its nucleosome (two copies of H2A, H2B, H3 and H4 class histones) form the chromosomes by the tighter packaging of H1 class histone. G9a has been reported to be critical for hippocampus-dependent long term memory (25) . Likewise, GLP is originally described as a gene encoding a G9a-like protein.
Although GLP and G9a independently exert histone lysine methyltransferase activity, many studies have demonstrated that they possess the same substrate specificities on histones (26, 27) . GLP and G9a can form a complex and induce the increase of H3K9me2, which is associated with the suppressed transcription of genes encoding (28) . For example, a recent study suggested that the inhibition of G9a/GLP in adult rats with the infusion of Bix inhibits the formation of H3K9me2 in the CA1 areas of the hippocampus and improves long-term memory (25) . In another study, P7 mice exposed to ethanol showed increased G9a/GLP-mediated H3K9me2 and decreased expression of histone H3, which may be associated with the increased cleaved caspase-3 (29) . Thus, histone modification may be another potential mechanism of sevoflurane-induced apoptosis and cognitive impairment. Evidence suggests that the learning and memory deficits may be the result of the toxic effects of sevoflurane on CNS development. Caspase-3, a marker of apoptosis, is significantly increased after sevoflurane exposure (20) , and our results were consistent with the previous study. Our study showed that repeated sevoflurane-exposure induced the increase of hippocampal G9a which was associated with the increased cleaved caspase-3. In our study, we found that G9a inhibitor Bix was able to decrease the levels of cleaved caspase-3, G9a, and H3K9me2 in the hippocampus as well as ameliorating the impaired cognitive performance. Bix pretreatment inhibited sevoflurane-induced cleaved caspase-3 activation in the hippocampus in a dose-dependent manner, and administration of Bix at the 1 mg/kg was more effective. It is possible that during the early brain development, sevoflurane-induced activation of G9a may suppress transcription of genes encoding for survival factors that induce a delay in neuronal development (30, 31 Figure D showed the latency spent to find the underwater platform during training phase. Figure E and F showed the time spent in the target quadrant and the part of orbits in testing day. Each data point represent mean ± the SEM (N=8, *P<0.05 or **P<0.01 versus the Con + Veh group; #P<0.05 or ##P<0.01 versus the Sev + Veh group).
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